Milataxel Unknown Status Phase 2 Trials for Mesothelioma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00685204An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma